2ioo

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2ioo" size="350" color="white" frame="true" align="right" spinBox="true" caption="2ioo, resolution 2.02&Aring;" /> '''Crystal structure of...)
Line 4: Line 4:
==Overview==
==Overview==
-
The p53 transcriptional regulator is the most frequently mutated protein, in human cancers and the majority of tumor-derived p53 mutations map to, the central DNA-binding core domain, with a subset of these mutations, resulting in reduced p53 stability. Here, the 1.55 A crystal structure of, the mouse p53 core domain with a molecule of, tris(hydroxymethyl)aminomethane (Tris) bound through multiple hydrogen, bonds to a region of p53 shown to be important for repair of a subset of, tumor-derived p53-stability mutations is reported. Consistent with the, hypothesis that Tris binding stabilizes the p53 core domain, equilibrium, denaturation experiments are presented that demonstrate that Tris binding, increases the thermodynamic stability of the mouse p53 core domain by 3.1, kJ mol(-1) and molecular-dynamic simulations are presented revealing an, overall reduction in root-mean-square deviations of the core domain of 0.7, A when Tris is bound. It is also shown that these crystals of the p53 core, domain are suitable for the multiple-solvent crystal structure approach to, identify other potential binding sites for possible core-domain, stabilization compounds. Analysis of the residue-specific temperature, factors of the high-resolution core-domain structure, coupled with a, comparison with other core-domain structures, also reveals that the L1, H1-S5 and S7-S8 core-domain loops, also shown to mediate various p53, activities, harbor inherent flexibility, suggesting that these regions, might be targets for other p53-stabilizing compounds. Together, these, studies provide a molecular scaffold for the structure-based design of, p53-stabilization compounds for development as possible therapeutic, agents.
+
The p53 transcriptional regulator is the most frequently mutated protein in human cancers and the majority of tumor-derived p53 mutations map to the central DNA-binding core domain, with a subset of these mutations resulting in reduced p53 stability. Here, the 1.55 A crystal structure of the mouse p53 core domain with a molecule of tris(hydroxymethyl)aminomethane (Tris) bound through multiple hydrogen bonds to a region of p53 shown to be important for repair of a subset of tumor-derived p53-stability mutations is reported. Consistent with the hypothesis that Tris binding stabilizes the p53 core domain, equilibrium denaturation experiments are presented that demonstrate that Tris binding increases the thermodynamic stability of the mouse p53 core domain by 3.1 kJ mol(-1) and molecular-dynamic simulations are presented revealing an overall reduction in root-mean-square deviations of the core domain of 0.7 A when Tris is bound. It is also shown that these crystals of the p53 core domain are suitable for the multiple-solvent crystal structure approach to identify other potential binding sites for possible core-domain stabilization compounds. Analysis of the residue-specific temperature factors of the high-resolution core-domain structure, coupled with a comparison with other core-domain structures, also reveals that the L1, H1-S5 and S7-S8 core-domain loops, also shown to mediate various p53 activities, harbor inherent flexibility, suggesting that these regions might be targets for other p53-stabilizing compounds. Together, these studies provide a molecular scaffold for the structure-based design of p53-stabilization compounds for development as possible therapeutic agents.
==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Chai, X.]]
[[Category: Chai, X.]]
-
[[Category: Fitzgerald, M.X.]]
+
[[Category: Fitzgerald, M X.]]
-
[[Category: Ho, W.C.]]
+
[[Category: Ho, W C.]]
[[Category: Luo, C.]]
[[Category: Luo, C.]]
[[Category: Marmorstein, R.]]
[[Category: Marmorstein, R.]]
Line 22: Line 22:
[[Category: ig fold]]
[[Category: ig fold]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jan 29 20:44:33 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:54:44 2008''

Revision as of 15:54, 21 February 2008

Image:2ioo.gif

2ioo, resolution 2.02Å

Drag the structure with the mouse to rotate

Crystal structure of the mouse p53 core domain

Overview

The p53 transcriptional regulator is the most frequently mutated protein in human cancers and the majority of tumor-derived p53 mutations map to the central DNA-binding core domain, with a subset of these mutations resulting in reduced p53 stability. Here, the 1.55 A crystal structure of the mouse p53 core domain with a molecule of tris(hydroxymethyl)aminomethane (Tris) bound through multiple hydrogen bonds to a region of p53 shown to be important for repair of a subset of tumor-derived p53-stability mutations is reported. Consistent with the hypothesis that Tris binding stabilizes the p53 core domain, equilibrium denaturation experiments are presented that demonstrate that Tris binding increases the thermodynamic stability of the mouse p53 core domain by 3.1 kJ mol(-1) and molecular-dynamic simulations are presented revealing an overall reduction in root-mean-square deviations of the core domain of 0.7 A when Tris is bound. It is also shown that these crystals of the p53 core domain are suitable for the multiple-solvent crystal structure approach to identify other potential binding sites for possible core-domain stabilization compounds. Analysis of the residue-specific temperature factors of the high-resolution core-domain structure, coupled with a comparison with other core-domain structures, also reveals that the L1, H1-S5 and S7-S8 core-domain loops, also shown to mediate various p53 activities, harbor inherent flexibility, suggesting that these regions might be targets for other p53-stabilizing compounds. Together, these studies provide a molecular scaffold for the structure-based design of p53-stabilization compounds for development as possible therapeutic agents.

About this Structure

2IOO is a Single protein structure of sequence from Mus musculus with as ligand. Full crystallographic information is available from OCA.

Reference

High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds., Ho WC, Luo C, Zhao K, Chai X, Fitzgerald MX, Marmorstein R, Acta Crystallogr D Biol Crystallogr. 2006 Dec;62(Pt 12):1484-93. Epub 2006, Nov 23. PMID:17139084

Page seeded by OCA on Thu Feb 21 17:54:44 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2ioo"
Personal tools